These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 20647702

  • 1. [Hepatocellular carcinoma].
    Kondo S, Ueno H, Morizane C, Okusaka T.
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1219-23. PubMed ID: 20647702
    [Abstract] [Full Text] [Related]

  • 2. Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials.
    Zhang T, Ding X, Wei D, Cheng P, Su X, Liu H, Wang D, Gao H.
    Anticancer Drugs; 2010 Mar; 21(3):326-32. PubMed ID: 20016366
    [Abstract] [Full Text] [Related]

  • 3. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ, Panel of Experts in HCC-Design Clinical Trials.
    J Natl Cancer Inst; 2008 May 21; 100(10):698-711. PubMed ID: 18477802
    [Abstract] [Full Text] [Related]

  • 4. Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.
    Rimassa L, Santoro A.
    Expert Rev Anticancer Ther; 2009 Jun 21; 9(6):739-45. PubMed ID: 19496710
    [Abstract] [Full Text] [Related]

  • 5. The present and the future landscape of treatment of advanced hepatocellular carcinoma.
    Rimassa L, Santoro A.
    Dig Liver Dis; 2010 Jul 21; 42 Suppl 3():S273-80. PubMed ID: 20547314
    [Abstract] [Full Text] [Related]

  • 6. Systemic therapies in hepatocellular carcinoma.
    Wörns MA, Weinmann A, Schuchmann M, Galle PR.
    Dig Dis; 2009 Jul 21; 27(2):175-88. PubMed ID: 19546557
    [Abstract] [Full Text] [Related]

  • 7. Molecular pathogenesis and targeted therapy of hepatocellular carcinoma.
    Zender L, Kubicka S.
    Onkologie; 2008 Oct 21; 31(10):550-5. PubMed ID: 18854656
    [Abstract] [Full Text] [Related]

  • 8. Targeted therapy of hepatocellular cancer.
    Wysocki PJ.
    Expert Opin Investig Drugs; 2010 Feb 21; 19(2):265-74. PubMed ID: 20074016
    [Abstract] [Full Text] [Related]

  • 9. Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan.
    Kudo M, Ueshima K.
    Oncology; 2010 Jul 21; 78 Suppl 1():154-66. PubMed ID: 20616599
    [Abstract] [Full Text] [Related]

  • 10. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
    Lencioni R, Chen XP, Dagher L, Venook AP.
    Oncologist; 2010 Jul 21; 15 Suppl 4():42-52. PubMed ID: 21115580
    [Abstract] [Full Text] [Related]

  • 11. Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.
    Zhu AX.
    Expert Opin Investig Drugs; 2010 May 21; 19(5):663-72. PubMed ID: 20367287
    [Abstract] [Full Text] [Related]

  • 12. Systemic treatment of hepatocellular carcinoma: dawn of a new era?
    Zhu AX.
    Ann Surg Oncol; 2010 May 21; 17(5):1247-56. PubMed ID: 20405329
    [Abstract] [Full Text] [Related]

  • 13. Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now?
    Finn RS.
    Clin Cancer Res; 2010 Jan 15; 16(2):390-7. PubMed ID: 20068087
    [Abstract] [Full Text] [Related]

  • 14. Growth factors as therapeutic targets in HCC.
    Furuse J.
    Crit Rev Oncol Hematol; 2008 Jul 15; 67(1):8-15. PubMed ID: 18434184
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapy in hepatocellular carcinoma.
    Okada S.
    Hepatogastroenterology; 1998 Aug 15; 45 Suppl 3():1259-63. PubMed ID: 9730385
    [Abstract] [Full Text] [Related]

  • 16. Molecularly targeted therapy in hepatocellular carcinoma.
    Huynh H.
    Biochem Pharmacol; 2010 Sep 01; 80(5):550-60. PubMed ID: 20371362
    [Abstract] [Full Text] [Related]

  • 17. Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma.
    Shao YY, Huang CC, Liang PC, Lin ZZ.
    Asia Pac J Clin Oncol; 2010 Jun 01; 6(2):80-8. PubMed ID: 20565419
    [Abstract] [Full Text] [Related]

  • 18. Targeted therapies for hepatocellular carcinoma.
    Skelton MR, O'Neil B.
    Clin Adv Hematol Oncol; 2008 Mar 01; 6(3):209-18. PubMed ID: 18391920
    [Abstract] [Full Text] [Related]

  • 19. Emerging targeted strategies in advanced hepatocellular carcinoma.
    Finn RS.
    Semin Liver Dis; 2013 Feb 01; 33 Suppl 1():S11-9. PubMed ID: 23457035
    [Abstract] [Full Text] [Related]

  • 20. Systemic therapy of hepatocellular carcinoma: are we making progress?
    Roxburgh P, Evans TR.
    Adv Ther; 2008 Nov 01; 25(11):1089-104. PubMed ID: 18972075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.